An official website of the United States government
Home
SEER Inquiry System - Report
Produced: 01/26/2026 2:51 AM
Question 20000528
Inquiry Details
References:
#1: SEER Program Code Man, 3rd Ed, 119
#2: SEER PCM,3rd Ed,Rev 1, 139e. January 2003
Question:
Hematologic Transplant and Endocrine Procedures--Breast: Is a bone marrow transplant first course of cancer-directed therapy for breast cancer? If yes, are time guidelines relating to the first "remission" the same as for those used in leukemia primaries?
Discussion:
Answer:
For cases diagnosed 1/1/2003 and after: A bone marrow transplant can be first course of therapy for cases in which there has been no progression of disease between the initial therapy (e.g., surgery, radiation, chemotherapy) and the bone marrow transplant. Code Hematologic Transplant and Endocrine Procedures field to 10-12 or 40 (depending on the type of bone marrow transplant performed).
Do not use leukemia treatment time guidelines when coding breast cancer treatment.
History:
For cases diagnosed prior to 1998: The transplant must be within 4 months or part of the planned 1st course of therapy (time guidelines changed starting with 1998 and later diagnoses).
For cases diagnosed prior to 2003: Cases coded using the SEER PCM 3rd Ed one-digit hormone and immunotherapy codes must be converted to the two-digit Hematologic Transplant and Endocrine Procedures scheme in Revision 1. Codes 82, 85, 86, 87 and 88 are invalid for cases using the conversion algorithm on page 139e, Revision 1.
